Alps Advisors Inc Bristol Myers Squibb CO Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alps Advisors Inc holds 490,458 shares of BMY stock, worth $28.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
490,458
Previous 642,932 23.72%
Holding current value
$28.6 Million
Previous $26.7 Million 4.94%
% of portfolio
0.17%
Previous 0.18%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$39.66 - $51.75 $6.05 Million - $7.89 Million
-152,474 Reduced 23.72%
490,458 $25.4 Million
Q2 2024

Aug 13, 2024
BUY
$40.25 - $52.99 $4.63 Million - $6.09 Million
114,959 Added 21.77%
642,932 $26.7 Million
Q1 2024

May 14, 2024
SELL
$47.98 - $54.4 $442,279 - $501,459
-9,218 Reduced 1.72%
527,973 $28.6 Million
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $20.9 Million - $24.9 Million
430,928 Added 405.53%
537,191 $27.6 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $1.03 Million - $1.15 Million
17,825 Added 20.16%
106,263 $6.17 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $155,834 - $173,030
-2,446 Reduced 2.69%
88,438 $5.66 Million
Q1 2023

May 10, 2023
SELL
$65.71 - $74.53 $174,525 - $197,951
-2,656 Reduced 2.84%
90,884 $6.3 Million
Q4 2022

Feb 14, 2023
SELL
$68.48 - $81.09 $24.6 Million - $29.2 Million
-359,487 Reduced 79.35%
93,540 $6.73 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $11,207 - $6.62 Million
86,213 Added 23.5%
453,027 $32.2 Million
Q2 2022

Aug 11, 2022
SELL
$72.62 - $79.98 $3.27 Million - $3.6 Million
-45,009 Reduced 10.93%
366,814 $28.2 Million
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $3.85 Million - $4.62 Million
-62,636 Reduced 13.2%
411,823 $30.1 Million
Q4 2021

Feb 09, 2022
BUY
$53.63 - $62.52 $25.4 Million - $29.7 Million
474,459 New
474,459 $29.6 Million
Q4 2020

Feb 03, 2021
SELL
$57.74 - $65.43 $17.9 Million - $20.3 Million
-310,475 Closed
0 $0
Q3 2020

Nov 04, 2020
SELL
$57.43 - $63.64 $2.4 Million - $2.66 Million
-41,824 Reduced 11.87%
310,475 $18.7 Million
Q2 2020

Aug 05, 2020
SELL
$54.82 - $64.09 $3.94 Million - $4.6 Million
-71,832 Reduced 16.94%
352,299 $20.7 Million
Q1 2020

May 06, 2020
SELL
$46.4 - $67.43 $7.31 Million - $10.6 Million
-157,622 Reduced 27.09%
424,131 $23.6 Million
Q4 2019

Feb 07, 2020
SELL
$49.21 - $64.19 $7.61 Million - $9.92 Million
-154,574 Reduced 20.99%
581,753 $37.3 Million
Q3 2019

Nov 04, 2019
SELL
$42.77 - $50.71 $2.35 Million - $2.78 Million
-54,859 Reduced 6.93%
736,327 $37.3 Million
Q2 2019

Aug 07, 2019
BUY
$44.62 - $49.34 $705,219 - $779,818
15,805 Added 2.04%
791,186 $35.9 Million
Q1 2019

May 01, 2019
SELL
$45.12 - $53.8 $368,675 - $439,599
-8,171 Reduced 1.04%
775,381 $37 Million
Q4 2018

Feb 04, 2019
BUY
$48.76 - $63.23 $35.5 Million - $46.1 Million
728,580 Added 1325.37%
783,552 $40.7 Million
Q3 2018

Oct 25, 2018
BUY
$55.19 - $62.25 $2.56 Million - $2.88 Million
46,343 Added 537.06%
54,972 $3.41 Million
Q2 2018

Jul 25, 2018
BUY
$50.53 - $62.98 $436,023 - $543,454
8,629 New
8,629 $529,000
Q1 2018

May 01, 2018
SELL
$59.92 - $68.98 $517,049 - $595,228
-8,629 Closed
0 $0
Q4 2017

Feb 05, 2018
SELL
$59.94 - $65.35 $68,451 - $74,629
-1,142 Reduced 11.69%
8,629 $529,000
Q3 2017

Nov 03, 2017
BUY
$55.23 - $63.74 $539,652 - $622,803
9,771
9,771 $623,000

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email